
60 Degrees and Yale to progress tafenoquin for babesiosis
60 Degrees Pharmaceuticals has signed a patent licence agreement with Yale School of Medicine and Yale School of Public Health, US, to progress the development and commercialisation of tafenoquine to treat and prevent babesiosis. Caused by Babesia, a …